NCT04278573 2024-04-30
Intralesional Vitamin D Injection for Treatment of Common Warts
Mayo Clinic
Phase 2 Completed
Clinical Trials
16 trialsNCT02100423 2024-04-12
Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Case Comprehensive Cancer Center
Phase 2 Completed
NCT01759771 2024-03-18
VD3PCa
VA Office of Research and Development
Phase 2 Completed
NCT04140292 2022-06-24
Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses
Case Comprehensive Cancer Center
Phase 2 Completed
NCT02186015 2021-05-14
SAFE-D
Loyola University
Phase 2 Completed
NCT02341495 2020-02-27
EXJADE
Loyola University
Phase 2 Terminated
NCT02726113 2019-12-03
Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy
Medical University of South Carolina
Phase 2 Completed
NCT01472445 2019-04-19
Vitamin D and Breast Cancer: Does Weight Make a Difference?
Stanford University
Phase 2 Terminated
NCT00499408 2018-11-21
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT00953225 2017-10-09
vit D & PCa
VA Office of Research and Development
Phase 2 Completed
NCT00859651 2017-09-27
Vitamin D in Postmenopausal Women at High Risk for Breast Cancer
Columbia University
Phase 2 Completed
NCT00416715 2017-07-11
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
University of Washington
Phase 2 Completed
NCT00321932 2017-03-09
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
University of Minnesota
Phase 2 Completed
NCT01074216 2016-02-03
Vitamin D Levels in Stage IV Colorectal Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00524680 2015-11-02
Vitamin D in Treating Patients With Prostate Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT01198548 2014-07-21
High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer
Roswell Park Cancer Institute
Phase 2 Terminated